Bacterial superinfection in critically ill patients with COVID-19- and influenza-associated pneumonia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00029634

Enrollment

190

Registered

2022-07-11

Start date

2019-02-07

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1 J10.0

Interventions

Group 1: Patients with COVID-19 pneumonia Evaluation of patient records, as well as evaluation of microbiological findings and their impact on the course of the disease. Group 2: Patients with influen

Eligibility

Sex/Gender

All

Age

0 Years to 99 Years

Inclusion criteria

Inclusion criteria: COVID-19 pneumonia, Influenza-pneumonia, admission to ICU

Exclusion criteria

Exclusion criteria: No COVID-19 or influenza confirmed pneumonia

Design outcomes

Primary

Measure	Time frame
To evaluate the impact on mortality of bacterial superinfection in patients with pneumonia caused either by COVID-19 or influenza in a tertiary ECMO referral center	—

Secondary

Measure	Time frame
To evaluate the overall incidence of bacterial superinfections, the associated bacterial pathogens and the characteristics of the patients associated with bacterial superinfection	—

Countries

Germany

Contacts

Public ContactJochen Schöttler

Universitätsmedizin MannheimAbteilung für Anästhesie und Operative Intensivmedizin

jochen.schoettler@umm.de06213837892670

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026